Hae
Aineistot 1-1 / 1
DEVELOPING RECOMBINANT ANTIBODIES FOR SORTING RECEPTOR SORLA
(2023-02-02)
Breast cancer is the most common malignancy and the leading cause of cancer-related death
among women. About 15 to 20% of breast cancers has amplification of the HER2 oncogene.
HER2 is a member of the epidermal growth ...